Just the Berries: Rheumatoid factors in patients with rheumatoid arthritis

Canadian Family Physician

Volumn 52, Issue FEB., 2006, Pages 180-186

  Wilson, Diane ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR; BIOLOGICAL MARKER;

ARTICLE; DISABILITY; DISEASE ACTIVITY; HUMAN; JOINT SWELLING; PREDICTION; PROBABILITY; PROGNOSIS; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SCREENING; SENSITIVITY AND SPECIFICITY; BLOOD;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; HUMANS; RHEUMATOID FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 33645316544     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Global Initiative for Asthma (GINA). Pocket guide for asthma management and prevention. Bethesda, Md: National Institutes of Health, National Heart, Lung and Blood Institute; 1998. Publication No. 95-3659B.
2. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 2. Bethesda, Md: National Institutes of Health, National Heart, Lung and Blood Institute; 1997. Publication No. 97-4051.
3. Lemiere C, Bai T, Balter M, Bayliff C, Becker A, Boulet LP, et al. Adult Asthma Consensus Guidelines Update 2003. Can Respir J 2004;11(Suppl A):9-18A.
4. O'Bryne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164(8 Pt 1):1392-7.
5. Pauweis RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Theraphy (FACET) International Study Group. N Engl J Med 1997;337:1405-11.
6. Fardon TC, Lee DK, Haggrat K, McFarlane LC, Lipworth BJ. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate. Am J Respir Crit Care Med 2004;170:960-6.